Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 23 hours agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 45 minutes agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 2 hours agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
COVID cases rising in L.A. County and California as new subvariants make mark
Los Angeles Times· 1 day agoCalifornia’s COVID numbers are on the rise thanks, in part, to new subvariants, suggesting an...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 57 minutes agoNovavax stock rocketed to a nearly two-year high in June, thanks to a $1.3 billion deal and the...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 3 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 5 hours agoCases are “stable or uncertain” in 18 others and are likely declining in one—Oklahoma. Do Vaccines...
Vaccine critics misrepresent US appeals court ruling over Covid-19 shots
AFP via Yahoo News· 2 days agoVaccine skeptics are claiming a US federal appeals court ruled in June 2024 that Covid-19 shots are...
Is There a New COVID Booster to Prevent Against FLiRT Variants?
Good Housekeeping via Yahoo News· 4 days agovaccine was rolled out, potentially making the currently available shot less effective than it once...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters via Yahoo News· 10 hours agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...